Literature DB >> 17631008

Antiphospholipid antibodies: effects on trophoblast and endothelial cells.

Silvia D'Ippolito1, Nicoletta Di Simone, Fiorella Di Nicuolo, Roberta Castellani, Alessandro Caruso.   

Abstract

PROBLEM: Antiphospholipid syndrome (APS) may affect placental functions through several possible mechanisms. Interaction of antiphospholipid antibodies (aPL) with cells involved in the coagulation cascade is thought to produce a procoagulant state. Thrombotic placental pathology is however not specific for the APS. METHOD OF STUDY: An analysis of published data.
RESULTS: It is now generally accepted that the clinically relevant aPL bind to proteins with affinity for phospholipids (PL), such as beta2-glycoprotein I (beta2-GPI). Following the attachment of beta2-GPI to trophoblast anionic PL, both molecules undergo conformational changes resulting in the exposure of cryptic epitopes within the structure of beta2-GPI. This may allow the subsequent binding of antibodies hence affecting trophoblast functions directly. Moreover anti-beta2-GPI antibodies induce the activation of endothelial cells (ECs), resulting in a proinflammatory state which favours the prothrombotic diathesis of the syndrome.
CONCLUSION: Numerous ameliorations in the APS knowledge have been introduced in the last few years. To have clarified the mechanism of antibody mediated damage on trophoblast and ECs represents an important step to explain the cellular events leading to pregnancy complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631008     DOI: 10.1111/j.1600-0897.2007.00500.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  6 in total

Review 1.  Impaired fibrinolysis in the antiphospholipid syndrome.

Authors:  Katie A Krone; Kristi L Allen; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

2.  ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice.

Authors:  Jane E Salmon; Chieko Mineo; Victoria Ulrich; Shari E Gelber; Milena Vukelic; Anastasia Sacharidou; Joachim Herz; Rolf T Urbanus; Philip G de Groot; David R Natale; Anirudha Harihara; Patricia Redecha; Vikki M Abrahams; Philip W Shaul
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

3.  Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.

Authors:  Maria Laura Bertolaccini; Gregorio Contento; Ross Lennen; Giovanni Sanna; Philip J Blower; Michelle T Ma; Kavitha Sunassee; Guillermina Girardi
Journal:  J Autoimmun       Date:  2016-05-06       Impact factor: 7.094

Review 4.  Pathophysiology of the antiphospholipid antibody syndrome.

Authors:  Rohan Willis; Silvia S Pierangeli
Journal:  Auto Immun Highlights       Date:  2011-03-24

5.  Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis.

Authors:  Xiaomei Yu; Li He
Journal:  Exp Ther Med       Date:  2020-11-19       Impact factor: 2.447

Review 6.  Advances in the Research on Anticardiolipin Antibody.

Authors:  Dan Wang; Wenxin Lv; Shichang Zhang; Jiexin Zhang
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.